[Vindesine-interferon alpha-2b combination in the treatment of metastases of cancer of the kidney].
Coiffier
B
B
Demolombe
S
S
Tabah
I
I
D000328:Adult; D000368:Aged; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011994:Recombinant Proteins; D014751:Vindesine / Q000627:therapeutic use*
D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D014751:Vindesine
Association vindésine-interféron alpha-2b pour le traitement des métastases du cancer du rein.